Mesoblast (MESO) Other Non Operating Income (2016 - 2025)
Mesoblast's (MESO) quarterly Other Non Operating Income came in at -$311000.0 in Q4 2025, up 60.08% year-on-year from -$194281.5 in Q4 2024, and down 150.49% quarter-over-quarter from $616000.0 in Q2 2025.
Mesoblast (MESO) Other Non Operating Income (2016 - 2025) Analysis & Trends
Mesoblast has disclosed Other Non Operating Income across 10 years of filings, most recently posting -$311000.0 for Q4 2025.
- Other Non Operating Income for Q4 2025 came in at -$311000.0, up 60.08% year-over-year; the trailing twelve-month figure through Dec 2025 was $339000.0 (up 143.52% YoY), and the FY2025 annual result was $616000.0, up 487.42% from the prior year.
- Other Non Operating Income came in at -$311000.0 for Q4 2025 at Mesoblast, down from $616000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $2.2 million in Q4 2023 to a low of -$5.9 million in Q4 2022.
- The 5-year median for Other Non Operating Income is $10000.0 (2022), against an average of -$383200.0.
- Across the five-year window, Other Non Operating Income plunged 7225.0% in 2021 and jumped 1830.0% in 2023, its largest moves.
- Mesoblast's Other Non Operating Income stood at $347000.0 in 2021, then slumped by 1799.14% to -$5.9 million in 2022, then surged by 137.4% to $2.2 million in 2023, then slumped by 135.33% to -$779000.0 in 2024, then soared by 60.08% to -$311000.0 in 2025.
- The last three Other Non Operating Income figures came in at -$311000.0 (Q4 2025), $616000.0 (Q2 2025), and -$779000.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Mesoblast | 21.68 Bn | 21.55 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -311,000.00 |
| Jun 30, 2025 | 616,000.00 |
| Dec 31, 2024 | -779,000.00 |
| Jun 30, 2024 | -159,000.00 |
| Dec 31, 2023 | 2.21 Mn |
| Jun 30, 2023 | 193,000.00 |
| Mar 31, 2023 | -86,000.00 |
| Dec 31, 2022 | -5.90 Mn |
| Sep 30, 2022 | 504,000.00 |
| Jun 30, 2022 | 10,000.00 |
| Mar 31, 2022 | 336,000.00 |
| Dec 31, 2021 | 347,000.00 |
| Sep 30, 2021 | 122,000.00 |
| Jun 30, 2021 | -1.43 Mn |
| Mar 31, 2021 | -1.43 Mn |
| Dec 31, 2020 | -417,000.00 |
| Sep 30, 2020 | -113,000.00 |
| Jun 30, 2020 | 20,000.00 |
| Mar 31, 2020 | -442,000.00 |
| Dec 31, 2019 | -375,000.00 |